The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission

Neuropharmacology

Volumn 96, Issue PA, 2015, Pages 105-112

  Rossi, Silvia ^a,b   Motta, Caterina ^a,b   Musella, Alessandra ^a,b   Centonze, Diego ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

CB1 receptor; GABA; Glutamate; IL 1 ; Multiple sclerosis; TNF; TRPV1

Indexed keywords

AMPA RECEPTOR; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; EXCITATORY AMINO ACID TRANSPORTER; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; AUTACOID; CYTOKINE;

ARTICLE; CELL ACTIVATION; DOWN REGULATION; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; HUMAN; INHIBITORY POSTSYNAPTIC POTENTIAL; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN; DISEASE MODEL; ENCEPHALITIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ENDOCANNABINOIDS; HUMANS; INFLAMMATION MEDIATORS; MULTIPLE SCLEROSIS; SYNAPTIC TRANSMISSION;

EID: 84930930081     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.09.022     Document Type: Review

References (109)

1. S. Alboni, D. Cervia, B. Ross, C. Montanari, A.S. Gonzalez, M. Sanchez-Alavez, M.C. Marcondes, D. De Vries, S. Sugama, N. Brunello, J. Blom, F. Tascedda, and B.J. Conti Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain J. Neuroimmunol. 214 2009 43 54
2. A. Bacci, J.R. Huguenard, and D.A. Prince Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids Nature 431 2004 312 316
3. B.S. Basavarajappa Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity Curr. Neuropharmacol. 5 2007 81 97
4. E.C. Beattie, D. Stellwagen, W. Morishita, J.C. Bresnahan, B.K. Ha, M. Von Zastrow, M.S. Beattie, and R.C. Malenka Control of synaptic strength by glial TNFalpha Science 295 2002 2282 2285
5. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39
6. M.L. Block, and J.S. Hong Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism Prog. Neurobiol. 76 2005 77 98
7. C. Börner, M. Smida, V. Höllt, B. Schraven, and J. Kraus Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling J. Biol. Chem. 284 2009 35450 35460
8. S.P. Brown, S.D. Brenowitz, and W.G. Regehr Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids Nat. Neurosci. 6 2003 1048 1057
9. A. Brusco, P.A. Tagliaferro, T. Saez, and E.S. Onaivi Ultrastructural localization of neuronal brain CB2 cannabinoid receptors Ann. N. Y. Acad. Sci. 1139 2008 450 457
10. G.A. Cabral, and F. Marciano-Cabral Cannabinoid receptors in microglia of the central nervous system: immune functional relevance J. Leukoc. Biol. 78 2005 1192 1197
11. P. Calabresi, D. Centonze, A. Pisani, L. Cupini, and G. Bernardi Synaptic plasticity in the ischaemic brain Lancet Neurol. 2 2003 622 629
12. D. Centonze, N. Battista, S. Rossi, N.B. Mercuri, A. Finazzi-Agrò, G. Bernardi, P. Calabresi, and M. Maccarrone A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic transmission Neuropsychopharmacology 29 2004 1488 1497
13. D. Centonze, S. Rossi, C. Prosperetti, V. Gasperi, V. De Chiara, M. Bari, A. Tscherter, F. Febbraro, G. Bernardi, and M. Maccarrone Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons Mol. Cell. Neurosci. 35 2007 302 310
14. D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, F. Fezza, V. De Chiara, L. Battistini, G. Bernardi, S. Bernardini, G. Martino, and M. Maccarrone The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis Brain 130 2007 2543 2553
15. D. Centonze, S. Rossi, A. Finazzi-Agrò, G. Bernardi, and M. Maccarrone The (endo) cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis Int. Rev. Neurobiol. 82 2007 171 186
16. D. Centonze, S. Rossi, V. De Chiara, C. Prosperetti, N. Battista, G. Bernardi, N.B. Mercuri, A. Usiello, and M. Maccarrone Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors Eur. J. Neurosci. 25 6 2007 1631 1640 2007 Mar
17. D. Centonze, L. Muzio, S. Rossi, F. Cavasinni, V. De Chiara, A. Bergami, A. Musella, M. D'Amelio, V. Cavallucci, A. Martorana, A. Bergamaschi, M.T. Cencioni, A. Diamantini, E. Butti, G. Comi, G. Bernardi, F. Cecconi, L. Battistini, R. Furlan, and G. Martino Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis J. Neurosci. 29 2009 3442 3452
18. V. Chevaleyre, and P.E. Castillo Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability Neuron 38 2003 461 472
19. B.W. Connors, and M.A. Long Electrical synapses in the mammalian brain Annu. Rev. Neurosci. 27 2004 393 418
20. A.J. Cunningham, C.A. Murray, L.A. O'Neill, M.A. Lynch, and J.J. O'Connor Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro Neurosci. Lett. 203 1996 17 20
21. G.D. Dalton, C.E. Bass, C.G. Van Horn, and A.C. Howlett Signal transduction via cannabinoid receptors C.N.S. Neurol. Disord. Drug Targets 8 2009 422 431
22. V. De Chiara, F. Angelucci, S. Rossi, A. Musella, F. Cavasinni, C. Cantarella, G. Mataluni, L. Sacchetti, F. Napolitano, M. Castelli, C. Caltagirone, G. Bernardi, M. Maccarrone, A. Usiello, and D. Centonze Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum J. Neurosci. 2010 8127 8137
23. V. De Chiara, F. Errico, A. Musella, S. Rossi, G. Mataluni, L. Sacchetti, A. Siracusano, M. Castelli, F. Cavasinni, G. Bernardi, A. Usiello, and D. Centonze Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum Neuropsychopharmacology 35 2010 374 387
24. V. De Chiara, C. Motta, S. Rossi, V. Studer, F. Barbieri, D. Lauro, G. Bernardi, and D. Centonze Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum Neuroscience 250 2013 232 239
25. L. De Petrocellis, and V. Di Marzo An introduction to the endocannabinoid system: from the early to the latest concepts Best Pract. Res. Clin. Endocrinol. Metab. 23 2009 1 15
26. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
27. M. Di Filippo, B. Picconi, A. Tozzi, V. Ghiglieri, A. Rossi, and P. Calabresi The endocannabinoid system in Parkinson's disease Curr. Pharm. Des. 14 2008 2337 2347
28. N. Eshhar, S. Striem, and A. Biegon HU-211, a non-psychotropic cannabinoid, rescues cortical neurones from excitatory amino acid toxicity in culture Neuroreport 5 1993 237 240
29. C. Favilla, T. Abel, and M.P. Kelly Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects J. Neurosci. 28 2008 13952 13956
30. F. Gardoni, M. Boraso, E. Zianni, E. Corsini, C.L. Galli, F. Cattabeni, M. Marinovich, M. Di Luca, and B. Viviani Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation J. Neuroinflamm. 8 2011 14
31. G.L. Gerdeman, J. Ronesi, and D.M. Lovinger Postsynaptic endocannabinoid release is critical to long-term depression in the striatum Nat. Neurosci. 5 2002 446 451
32. G. Grasselli, S. Rossi, A. Musella, A. Gentile, S. Loizzo, L. Muzio, C. Di Sanza, F. Errico, G. Musumeci, N. Haji, D. Fresegna, H. Sepman, V. De Chiara, R. Furlan, G. Martino, A. Usiello, G. Mandolesi, and D. Centonze Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis Br. J. Pharmacol. 168 2013 502 517
33. B.A. Grueter, G. Brasnjo, and R.C. Malenka Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens Nat. Neurosci. 13 2010 1519 1525
34. P. Gubellini, B. Picconi, M. Bari, N. Battista, P. Calabresi, D. Centonze, G. Bernardi, A. Finazzi-Agrò, and M. Maccarone Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission J. Neurosci. 22 2002 6900 6907
35. O.M. Habayeb, A.H. Taylor, S.C. Bell, D.J. Taylor, and J.C. Konje Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation Endocrinology 149 2008 5052 5060
36. N. Haji, G. Mandolesi, A. Gentile, L. Sacchetti, D. Fresegna, S. Rossi, A. Musella, H. Sepman, C. Motta, V. Studer, V. De Chiara, G. Bernardi, P. Strata, and D. Centonze TNF-α-mediated anxiety in a mouse model of multiple sclerosis Exp. Neurol. 237 2012 296 303
37. B.D. Heifets, and P.E. Castillo Endocannabinoid signaling and long-term synaptic plasticity Annu. Rev. Physiol. 71 2009 283 306
38. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 1991 563 583
39. E.L. Hill, T. Gallopin, I. Ferezou, B. Cauli, J. Rossier, P. Schweitzer, and B. Lambolez Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons J. Neurophysiol. 97 2007 2580 2589
40. C.J. Hillard Endocannabinoids and vascular function J. Pharmacol. Exp. Ther. 294 2000 27 32
41. A.C. Howlett Efficacy in CB1 receptor-mediated signal transduction Br. J. Pharmacol. 142 2004 1209 1218
42. C.C. Huang, S.W. Lo, and K.S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons J. Physiol. 532 2001 731 748
43. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol. Rev. 89 2009 309 380
44. R.A. Khairova, R. Machado-Vieira, J. Du, and H.K. Manji A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder Int. J. Neuropsychopharmacol. 12 2009 561 578
45. J. Kim, M. Isokawa, C. Ledent, and B.E. Alger Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus J. Neurosci. 22 2002 10182 10191
46. S.H. Kim, S.J. Won, X.O. Mao, K. Jin, and D.A. Greenberg Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity Mol. Pharmacol. 69 2006 691 696
47. E. Koutsilieri, and P. Riederer Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease Park. Relat. Disord. 13 2007 S329 S331
48. A.C. Kreitzer, and W.G. Regehr Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells Neuron 29 2001 717 727
49. A.Y. Lai, R.D. Swayze, A. El-Husseini, and C. Song Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons J. Neuroimmunol. 175 2006 97 106
50. S.F. Lee, C. Newton, R. Widen, H. Friedman, and T.W. Klein Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation Eur. J. Pharmacol. 423 2001 235 241
51. D. Leonoudakis, P. Zhao, and E.C. Beattie Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity J. Neurosci. 28 2008 2119 2130
52. F. Loría, S. Petrosino, M. Hernangómez, L. Mestre, A. Spagnolo, F. Correa, V. Di Marzo, F. Docagne, and C. Guaza An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis Neurobiol. Dis. 37 2010 166 176
53. M. Maccarrone, S. Rossi, M. Bari, V. De Chiara, F. Fezza, A. Musella, V. Gasperi, C. Prosperetti, G. Bernardi, A. Finazzi-Agrò, B.F. Cravatt, and D. Centonze Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum Nat. Neurosci. 11 2008 152 159
54. M. Maccarrone, V. De Chiara, V. Gasperi, M.T. Viscomi, S. Rossi, S. Oddi, M. Molinari, A. Musella, A. Finazzi-Agrò, and D. Centonze Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum J. Neurochem. 109 2009 371 381
55. G. Mandolesi, A. Musella, A. Gentile, G. Grasselli, N. Haji, H. Sepman, D. Fresegna, S. Bullitta, F. De Vito, G. Musumeci, C. Di Sanza, P. Strata, and D. Centonze Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis J. Neurosci. 17 2013 12105 12121
56. I. Marin, and J. Kipnis Learning and memory. and the immune system Learn. Mem. 20 2013 601 606
57. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, A. Cannich, S.C. Azad, M.G. Cascio, S.O. Gutiérrez, M. van der Stelt, M.L. López-Rodriguez, E. Casanova, G. Schütz, W. Zieglgänsberger, V. Di Marzo, C. Behl, and B. Lutz CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
58. G. Marsicano, and B. Lutz Neuromodulatory functions of the endocannabinoid system J. Endocrinol. Investig. 29 2006 27 46
59. S.J. Mathew, and S. Ho Etiology and neurobiology of social anxiety disorder J. Clin. Psychiatry 67 Suppl. 12 2006 9 13
60. M.P. Mattson Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders Neuromol. Med. 3 2003 65 94
61. J.C. McEachern, and C.A. Shaw The plasticity-pathology continuum: defining a role for the LTP phenomenon J. Neurosci. Res. 58 1999 42 61
62. R. Min, and T. Nevian Astrocyte signaling controls spike timing-dependent depression at neocortical synapses Nat. Neurosci. 15 2012 746 753
63. G. Moldrich, and T. Wenger Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study Peptides 21 2000 1735 1742
64. F. Mori, R. Nisticò, G. Mandolesi, S. Piccinin, D. Mango, H. Kusayanagi, N. Berretta, A. Bergami, A. Gentile, A. Musella, C.G. Nicoletti, F. Nicoletti, F. Buttari, N.B. Mercuri, G. Martino, R. Furlan, and D. Centonze Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis Neuromol. Med. 16 2014 38 51
65. C.A. Murray, and M.A. Lynch Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation J. Neurosci. 18 1998 2974 2981
66. A. Musella, V. De Chiara, S. Rossi, C. Prosperetti, G. Bernardi, M. Maccarrone, and D. Centonze TRPV1 channels facilitate glutamate transmission in the striatum Mol. Cell. Neurosci. 40 2009 89 97
67. A. Musella, V. De Chiara, S. Rossi, F. Cavasinni, M. Castelli, C. Cantarella, G. Mataluni, G. Bernardi, and D. Centonze Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum Neuroscience 167 2010 864 871
68. A. Musella, H. Sepman, G. Mandolesi, A. Gentile, D. Fresegna, N. Haji, A. Conrad, B. Lutz, M. Maccarrone, and D. Centonze Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis Neuropharmacology 79 2014 567 572
69. G. Musumeci, G. Grasselli, S. Rossi, V. De Chiara, A. Musella, C. Motta, V. Studer, G. Bernardi, N. Haji, H. Sepman, D. Fresegna, M. Maccarrone, G. Mandolesi, and D. Centonze Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis Neurobiol. Dis. 43 2011 669 677
70. M. Navarrete, and A. Araque Endocannabinoids mediate neuron-astrocyte communication Neuron 57 2008 883 893
71. T. Ohno-Shosaku, T. Maejima, and M. Kano Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals Neuron 29 2001 729 738
72. T. Ohno-Shosaku, Y. Hashimotodani, M. Ano, S. Takeda, H. Tsubokawa, and M. Kano Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons J. Physiol. 584 2007 407 418
73. D. Parolaro Presence and functional regulation of cannabinoid receptors in immune cells Life Sci. 65 1999 637 644
74. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
75. M.H. Rashid, M. Inoue, S. Kondo, T. Kawashima, S. Bakoshi, and H. Ueda Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain J. Pharmacol. Exp. Ther. 304 2003 940 948
76. F.M. Ross, S.M. Allan, N.J. Rothwell, and A. Verkhratsky A dual role for interleukin-1 in LTP in mouse hippocampal slices J. Neuroimmunol. 144 2003 61 67
77. S. Rossi, V. De Chiara, A. Musella, H. Kusayanagi, G. Mataluni, G. Bernardi, A. Usiello, and D. Centonze Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum J. Neurosci. 28 2008 7284 7292
78. S. Rossi, V. De Chiara, A. Musella, L. Sacchetti, C. Cantarella, M. Castelli, F. Cavasinni, C. Motta, V. Studer, G. Bernardi, B.F. Cravatt, M. Maccarrone, A. Usiello, and D. Centonze Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition Mol. Pharmacol. 78 2010 260 268
79. S. Rossi, V. De Chiara, R. Furlan, A. Musella, F. Cavasinni, L. Muzio, G. Bernardi, G. Martino, and D. Centonze Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis Brain Behav. Immun. 24 2010 1379 1385
80. S. Rossi, V. De Chiara, A. Musella, M. Cozzolino, G. Bernardi, M. Maccarrone, N.B. Mercuri, M.T. Carrì, and D. Centonze Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis Amyotroph. Lateral. Scler. 11 2010 83 90
81. S. Rossi, R. Furlan, V. De Chiara, L. Muzio, A. Musella, C. Motta, V. Studer, F. Cavasinni, G. Bernardi, G. Martino, B.F. Cravatt, B. Lutz, M. Maccarrone, and D. Centonze Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis Brain Behav. Immun. 25 2011 1242 1248
82. S. Rossi, L. Muzio, V. De Chiara, G. Grasselli, A. Musella, G. Musumeci, G. Mandolesi, R. De Ceglia, S. Maida, E. Biffi, A. Pedrocchi, A. Menegon, G. Bernardi, R. Furlan, G. Martino, and D. Centonze Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis Brain Behav. Immun. 25 2011 947 956
83. S. Rossi, F. Buttari, V. Studer, C. Motta, P. Gravina, M. Castelli, V. Mantovani, V. De Chiara, A. Musella, S. Fiore, S. Masini, G. Bernardi, M. Maccarrone, S. Bernardini, and D. Centonze The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis Mult. Scler. 17 2011 281 288
84. S. Rossi, R. Furlan, V. De Chiara, C. Motta, V. Studer, F. Mori, A. Musella, A. Bergami, L. Muzio, G. Bernardi, L. Battistini, G. Martino, and D. Centonze Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis Ann. Neurol. 71 2012 76 83
85. S. Rossi, V. Studer, C. Motta, V. De Chiara, F. Barbieri, G. Bernardi, and D. Centonze Inflammation inhibits GABA transmission in multiple sclerosis Mult. Scler. 18 2012 1633 1635
86. S. Rossi, L. Sacchetti, F. Napolitano, V. De Chiara, C. Motta, V. Studer, A. Musella, F. Barbieri, M. Bari, G. Bernardi, M. Maccarrone, A. Usiello, and D. Centonze Interleukin-1b causes anxiety by interacting with the endocannabinoid system J. Neurosci. 32 2012 13896 13905
87. S. Rossi, M. Bozzali, M. Bari, F. Mori, V. Studer, C. Motta, F. Buttari, M. Cercignani, P. Gravina, N. Mastrangelo, M. Castelli, R. Mancino, C. Nucci, F. Sottile, S. Bernardini, M. Maccarrone, and D. Centonze Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis PLoS ONE 8 2013 e82848
88. S. Rossi, C. Motta, V. Studer, F. Barbieri, F. Buttari, A. Bergami, G. Sancesario, S. Bernardini, G. De Angelis, G. Martino, R. Furlan, and D. Centonze Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration Mult. Scler. 20 2014 304 312
89. S. Rossi, V. Studer, C. Motta, G. Germani, G. Macchiarulo, F. Buttari, R. Mancino, M. Castelli, V. De Chiara, S. Weiss, G. Martino, R. Furlan, and D. Centonze Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis J. Neuroinflamm. 11 2014 32
90. C. Salio, E. Cottone, M. Conrath, and M.F. Franzoni CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers J. Chem. Neuroanat. 24 2002 153 162
91. P. Sikand, and L.S. Premkumar Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse J. Physiol. 581 2007 631 647
92. D. Stellwagen, E.C. Beattie, J.Y. Seo, and R.C. Malenka Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha J. Neurosci. 25 2005 3219 3228
93. D. Stellwagen, and R.C. Malenka Synaptic scaling mediated by glial TNF-alpha Nature 440 2006 1054 1059
94. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, and K. Waku 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun. 215 1995 89 97
95. S. Suzuki, K. Kiyosue, S. Hazama, A. Ogura, M. Kashihara, T. Hara, H. Koshimizu, and M. Kojima Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development J. Neurosci. 27 2007 6417 6427
96. B. Szabo, L. Dorner, C. Pfreundtner, W. Norenberg, and K. Starke Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum Neuroscience 85 1998 395 403
97. A. Tóth, Y. Wang, N. Kedei, R. Tran, L.V. Pearce, S.U. Kang, M.K. Jin, H.K. Choi, J. Lee, and P.M. Blumberg Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1 Life Sci. 76 2005 2921 2932
98. S. Tyring, A. Gottlieb, K. Papp, K. Gordon, C. Leonardi, A. Wang, D. Lalla, M. Woolley, A. Jahreis, R. Zitnik, D. Cella, and R. Krishnan Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial Lancet 367 2006 29 35
99. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J.S. Davison, L.J. Marnett, V. Di Marzo, Q.J. Pittman, K.D. Patel, and K.A. Sharkey Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332
100. N. Varma, G.C. Carlson, C. Ledent, and B.E. Alger Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus J. Neurosci. 21 2001 RC188
101. C.W. Vaughan, and M.J. Christie Retrograde signalling by endocannabinoids Handb. Exp. Pharmacol. 168 2005 367 383
102. B. Viviani, S. Bartesaghi, F. Gardoni, A. Vezzani, M.M. Behrens, T. Bartfai, M. Binaglia, E. Corsini, M. Di Luca, C.L. Galli, and M. Marinovich Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases J. Neurosci. 23 2003 8692 8700
103. L. Wang, and D.H. Wang TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice Circulation 112 2005 3617 3623
104. S. Weiss, F. Mori, S. Rossi, and D. Centonze Disability in multiple sclerosis: when synaptic long-term potentiation fails Neurosci. Biobehav. Rev. 43 2014 88 99
105. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 2001 588 592
106. H.H. Yin, and D.M. Lovinger Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling Proc. Natl. Acad. Sci. U. S. A. 103 2006 8251 8256
107. R. Yirmiya, and I. Goshen Immune modulation of learning, memory, neural plasticity and neurogenesis Brain Behav. Immun. 25 2011 181 213
108. P. Zhao, D. Leonoudakis, M.E. Abood, and E.C. Beattie Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity Neuropharmacology 58 2010 551 558
109. E.P. Zorrilla, L. Luborsky, J.R. McKay, R. Rosenthal, A. Houldin, A. Tax, R. McCorkle, D.A. Seligman, and K. Schmidt The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav. Immun. 15 2001 199 226